Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

NCT02360579 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Iovance Biotherapeutics, Inc.